Company intelligence / Profile preview

Sensi.AI

Austin, Texas, United Statessensi.ai ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Sensi.AI’s technology is commercially deployed with over 80% of the largest home care providers in the U.S. and has recently expanded into Canada. The system provides continuous audio-based monitoring to detect anomalies, trends, and risks related to seniors’ physical, emotional, and cognitive health. It enables early intervention for issues such as falls or cognitive decline and supports agencies with actionable insights that have been shown to reduce hospitalizations and improve client satisfaction.

Therapeutic areas: OtherNeurology
Modalities: DeviceNon-pharmacological therapy (AI-driven monitoring and analytics platform for care delivery)
Industry: Physiological Monitoring

Partnerships

Right at Home Canada

Beyond the preview

Go deeper on Sensi.AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sensi.AI.

Explore the full profile